Israel’s Skip Therapeutics is partnering with Sheba Medical Center to develop ASO-based (short RNA sequences) treatments for rare genetic diseases. Skip’s ASOs (Antisense Oligonucleotide) aim to restore the function of mutated genes in genetic disorders.
Developing RNA-based treatments for rare diseases
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.